Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in plasma therapy-sensitive aHUS
NCT00838513Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jul 2009
- Primary completion
- Oct 2010
- Countries
- 7
01
Overview
A Phase 2 trial of eculizumab in atypical hemolytic uremic syndrome (aHUS), sponsored by Alexion Pharmaceuticals. Started Jul 2009; status: completed.
02
Drugs
eculizumab
03
Conditions
atypical hemolytic uremic syndrome (aHUS)
Beyond the preview
Go deeper on NCT00838513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838513.